KUWAIT NBK SOLD ITS SHARES IN BAVET ILAC..
Kuwaiti National Bank of Kuwait (NBK), one of the largest financial institutions in the Middle East, is one of the first Gulf investors to come to Turkey.
Having bought 34.3 percent of Turkish Bank for 160 million dollars in 2007, its most important investment, NBK also bought shares from important companies of Turkey with its fund company.
NBK, which is a partner in companies such as Dünya Göz Hospitals, Yudum Gıda, Aras Kargo, Dem İlaç, Kılıç Deniz, exited these companies due to its fund feature and sold its shares over time.
Yatsan, Sistem-9, Perkon and Bavet Kimya remained in NBK’s Turkey portfolio. In July 2012, NBK acquired 50 percent of Bavet İlaç, which works for the pet market, and made significant contributions to the growth of the company.
That partnership ended recently. Bavet repurchased 50 percent of NBK’s controlling stake. Thus, after 8 years, NBK completed its exit from the Turkish company Bavet.
Bavet İlaç operates in the fields of animal and environmental health.
Bavet İlaç, which started its activities in 2000, continues its activities in the fields of animal and environmental health. Offering bovine, ovine and livestock products to its customers in the field of animal health, Bavet İlaç opened its Arion Pharmaceuticals production facility in 2012, following its partnership with NBK Capital.
NBK has banks in the UK, Lebanon, Iraq and Qatar.
Founded in 1952 by the decision of the Emir of Kuwait, Abdullah Al Salem Al Sabah, NBK has 68 branches in Kuwait and a total of 143 branches around the world. NBK has branches in Geneva, London, Paris, New York, Singapore and China.
The Kuwaiti bank, which manages 58.6% of Boubyan Bank in London, also owns NBK International PLC. NBK Lebanon, NBK Banque Privee Suisse, Credit Bank of Iraq, National Investors Group Holdings Limited in Cayman Islands, Al Watany Bank of Egypt S.A.E. in Egypt. and the International Bank of Qatar, NBK has assets of $86.3 billion. It is stated that NBK, which has a revenue of 3.2 billion dollars, has 6 thousand employees.
LET’S KNOW BAVET PHARMACEUTICALS..!
Bavet İlaç Sanayi ve Ticaret Anonim Şirketi, which was founded by Zekeriya Nergiz in 2000, was established with the aim of providing high quality products & services to the animal and environmental health sectors.
Bavet İlaç, which has been selling and distributing international companies and its own licensed products since the day it was founded, Bavet Group, which has updated its product portfolio in line with the fact that GMP & GLP certificates have now become a sectoral necessity, and Arion Pharmaceuticals, Turkey’s first GMP production facility, has also become GMP’s. manufactures products.
Bavet Pharmaceuticals and IPM pharmaceutical products operating in the fields of environment and animal health within the Bavet Group; It exports to 5 countries in 4 continents, namely Eastern Europe, Western Asia, Middle East and North Africa and South America.
Currently, Bavet has 55 VTU licenses, 28 VTU licenses of IPM as animal health veterinary medicinal products, more than 60 commercial products of two companies and more than 20 as feed additives.
Bavet has 23 licensed products and IPM has 2 licensed products in the field of environmental health.
